| Kristin Monaghan, PhD, FACMG, ACMG Board member and one of the authors of the ACMG Choosing Wisely list of recommendations said, "ACMG is delighted to be part of the ABIM Foundation’s Choosing Wisely campaign. As genetics and genomics continue to play an increasingly important role in all aspects of patient care, we know that patients will have more questions and we hope this Choosing Wisely list provides some helpful direction for clinician-patient dialogue about genetic and genomic testing." "All clinicians, including medical geneticists, play a key role in making sure that the appropriate tests and treatments are prescribed. We hope the ACMG recommendations will help inform important conversations about genetic tests on this list," added ACMG vice-president of Clinical Genetics Maren T. Scheuner, MD, MPH, FACMG, and co-author of the ACMG Choosing Wisely List of Recommendations. How this list was created The ACMG list relies on the expertise of a number of committees that develop clinical practice guidelines and laboratory technical standards and guidelines. For the Choosing Wisely campaign, input from the Laboratory Quality Assurance Committee, Professional Practice and Guidelines Committee and Therapeutics Committee was solicited. A list of 18 items was reviewed by the ACMG Board of Directors and the 5 items currently thought to most likely improve quality and reduce costs related to genetic testing were selected. To learn more about Choosing Wisely and to view the complete lists of recommendations click here. Note: The items on the ACMG list are provided solely for informational purposes and are not intended as a substitute for consultation with a medical professional. In determining the propriety of any specific procedure or test, patients should consult with their individual clinicians and clinicians should apply their own professional judgment to the specific clinical circumstances presented by each individual patient. |
No hay comentarios:
Publicar un comentario